Primary tumor-derived systemic nANGPTL4 inhibits metastasis

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Tumor and metastasis interactions are bidirectional but poorly understood.
• The molecular mechanisms of tumor crosstalk require further investigation.

Purpose of the Study:

• To investigate the context-dependent roles of angiopoietin-like 4 (ANGPTL4) fragments in cancer.
• To identify novel biomarkers and therapeutic targets for metastasis.

Main Methods:

• Preclinical studies in multiple tumor models.
• Analysis of ANGPTL4 fragments in patient tumor tissues and circulation.
• WNT signaling pathway analysis.

Main Results:

• Proteolytic fragments of ANGPTL4 exhibit distinct protumorigenic (C-terminal fragment, cANGPTL4) and antitumorigenic (N-terminal fragment, nANGPTL4) functions.
• nANGPTL4 inhibited metastasis, reduced vascularity, and improved survival in preclinical models.
• nANGPTL4 levels in circulation inversely correlated with disease progression in patients.

Conclusions:

• The function of ANGPTL4 is dependent on its proteolytic cleavage and spatial context.
• nANGPTL4 is a potential biomarker for tumor progression and an antimetastatic therapeutic agent.